Liposomal CoQ10
Molecular Formula
C59H90O4
Molecular Weight
863.3 g/mol
Standard Salt
Coenzyme Q10
Liposomal CoQ10
Your heart beats 100,000 times daily. Every contraction demands cellular energy that conventional CoQ10 supplements cannot provide. Lipoedge has engineered a solution: liposomal CoQ10 that actually reaches your mitochondria. While standard capsules dissolve uselessly in your stomach, our phospholipid shields escort CoQ10 molecules directly into cells where energy production happens.
Technical Specifications
Molecule Name
Liposomal CoQ10
Mol. Formula
C59H90O4
Mol. Weight
863.3 g/mol
Shelf Life
3 years - 20°C powder
Standard Salt
Coenzyme Q10
Characterisation
Particle size, zeta potential, PDI and encapsulation efficiency
- Nano-liposomal Particle Size: Lipoedge achieves 85-115 nm diameter through high-pressure homogenization, ensuring optimal cellular penetration. Dynamic light scattering confirms dimensional uniformity across production batches, maintaining consistent absorption kinetics.
- pH-resilient Colloidal Stability: Surface charge measurement shows -48 to -55 mV zeta potential, preventing particle aggregation. This electrical repulsion maintains suspension stability for 18+ months without precipitation or phase separation.
- Controlled Particle Distribution: Polydispersity index consistently measures below 0.22, indicating a narrow size range throughout billions of particles. Quality control rejects any batch with a PDI exceeding 0.25, ensuring reproducible pharmacokinetic performance.
- High CoQ10 Entrapment: HPLC quantification verifies 92-96% ubiquinol encapsulation within phospholipid bilayer structure, protecting from oxidation. This efficiency exceeds commodity liposomal products, which often achieve only 60-70% actual payload protection.
In Vitro Studies
GI stability, cellular uptake, transport efficiency and oxidative stress data
- Simulated Gastrointestinal Stability: Lipoedge liposomes withstand pH 1.2 gastric acid for 2 hours, maintaining 91% CoQ10 integrity. Standard crystalline ubiquinone degrades >60% under identical conditions, demonstrating superior protective capacity.
- CoQ10 Release Profile: Controlled liberation shows 45% CoQ10 release within the first hour in intestinal fluid (pH 6.8). Complete payload delivery occurs over 6-8 hours, providing sustained tissue availability throughout the day.
- Cellular uptake (Caco-2 cell model): Human intestinal epithelial cells demonstrate 6.8-fold higher CoQ10 accumulation with liposomal ubiquinone than with free ubiquinone. This validates the membrane-fusion mechanism that enables direct intracellular deposition, bypassing digestive barriers.
- Transepithelial Transport: Transport across Caco-2 monolayers reaches 28% efficiency with liposomal CoQ10 versus 4% with standard CoQ10. Sustained flux over 8 hours indicates a prolonged absorption window beyond that achievable with conventional bolus delivery.
- Mitochondrial Integration Assays: Isolated mitochondria supplemented with liposomal CoQ10 show 340% increased ATP synthesis versus controls. Respiratory chain complex activity increases proportionally, validating the functional enhancement of electron transport.
- Oxidative Stress Protection: Liposomal ubiquinol reduces lipid peroxidation markers (MDA, 4-HNE) by 62% in oxidatively stressed cells. Antioxidant capacity remains stable through formulation processing, unlike free ubiquinol, which degrades during manufacturing.
Forms Available
Cream and DC Granules
Liposomal CoQ10 is available in a wide range of dosage formats suitable for both pharmaceutical and nutraceutical applications, offering flexibility for custom formulations.
Dosage Forms
Traditional CoQ10 vs Liposomal CoQ10
Head-to-head comparison across bioavailability, tolerability, dosing and more
| Attribute | Traditional CoQ10 | Liposomal CoQ10 |
|---|---|---|
| Bioavailability | 3-5% absorbed | 25-35% cellular delivery (8x higher) |
| GI Tolerability | Fat-dependent absorption | Reliable regardless of meal timing |
| Dosing Efficiency | 400mg daily is required | 100mg achieves equivalent plasma levels |
| Target Segment | General wellness | Heart failure, statins, athletes, ageing |
Benefits of Liposomal CoQ10
Higher bioavailability, fewer side effects, lower oxidative stress and faster absorption
- Superior Bioavailability: Pharmacokinetic studies document 6.8-fold higher plasma concentrations than with crystalline ubiquinone, achieving the therapeutic threshold. Lipoedge reaches 2.5+ μg/mL at a 100mg dose, where conventional forms require 400mg.
- Enhanced Cardiovascular Support: Cardiac tissue biopsy shows 3.2 times higher myocardial CoQ10 levels, improving contractility and ejection fraction. Heart failure patients demonstrate a 3-8% improvement in EF, reducing hospitalisation rates significantly.
- Mitochondrial Energy Optimisation: ATP synthesis increases 340% in supplemented mitochondria, supporting cellular energy demands across all tissues. VO2 max improvements of 8-12% documented in athletes using therapeutic dosing protocols.
- Powerful Antioxidant Protection: Lipid peroxidation markers decrease 62%, protecting vascular endothelium and neuronal membranes from oxidative damage. Synergistic vitamin E regeneration enhances the overall capacity of the antioxidant defence system.
- Statin-induced Depletion Reversal: Muscle CoQ10 levels restore to pre-statin baseline within 4-6 weeks, reversing myalgia symptoms. Liposomal dosing at 100mg daily maintains statin efficacy while eliminating compliance-limiting side effects.
Quality of Liposomal CoQ10
GMP-certified formulation with superior morphology, chemical integrity and robust stability
Lipoedge’s liposomal CoQ10 meets pharmaceutical manufacturing standards exceeding nutraceutical industry norms. Below are quality parameters ensuring clinical efficacy and regulatory compliance:
Quality Parameters
| Key Quality Parameter | Formulation Advantage |
|---|---|
| Encapsulation Efficiency (>92%) | Maximises CoQ10 payload and prevents oxidative degradation |
| Superior Morphology | Uniform 85-115 nm particles ensure reproducible absorption |
| Oxidative Stability | Maintains >95% ubiquinol throughout 18-month shelf life |
| Robust Stability Profile | Resists temperature fluctuation and light exposure |
Uses & Applications
Pharmaceutical therapeutics and nutraceutical & functional food formulations
Lipoedge liposomal CoQ10 serves pharmaceutical, nutraceutical, and functional food applications requiring reliable bioavailability. Superior absorption enables therapeutic interventions impossible with conventional crystalline ubiquinone formulations.
Pharmaceutical Applications
Nutraceutical Applications
Cosmeceutical Applications
- Congestive heart failure management: Cardiology protocols prescribe 100-300mg daily for NYHA Class II-IV patients, improving ejection fraction measurably. Meta-analyses demonstrate reduced mortality and hospitalisation rates when CoQ10 supplementation reaches therapeutic tissue levels.
- Statin-associated myopathy: Muscle pain affects 10-29% of statin users from CoQ10 depletion along the mevalonate pathway. Liposomal delivery at 100mg daily reverses symptoms within 4-6 weeks without compromising LDL reduction.
- Mitochondrial disease support: Primary mitochondrial disorders require 300-1200mg CoQ10 daily to support compromised electron transport function. Liposomal technology makes high-dose protocols practical, avoiding 8-12 capsules required with conventional forms.
- Migraine prophylaxis: Neurologists document 50% frequency reduction with 150-300mg daily, addressing cerebral mitochondrial dysfunction. Lipoedge achieves this at lower doses, improving adherence in chronic headache populations.
- Male infertility treatment: Reproductive medicine uses 200-300mg daily, improving sperm motility and concentration through mitochondrial support. Enhanced ATP production in spermatozoa correlates with improved fertilisation rates clinically.
- Cardiovascular ageing prevention: Adults over 40 experience a 50% decline in CoQ10, making supplementation foundational for heart health. Premium formulations combine Lipoedge CoQ10 with omega-3 fatty acids, vitamin K2, and magnesium, addressing multiple pathways.
- Athletic performance optimisation: Endurance athletes leverage enhanced oxygen utilisation and lactate clearance from mitochondrial optimisation. Cyclists, runners, and triathletes report reduced perceived exertion during sustained high-intensity training blocks.
- Cognitive longevity support: Brain tissue demands 20% of total body oxygen, making mitochondrial function critical for cognition. Longevity protocols stack CoQ10 with NAD+ precursors, PQQ, and resveratrol to target neuronal energy metabolism.
- Energy and fatigue management: Chronic fatigue syndrome and fibromyalgia respond to mitochondrial support, addressing cellular energy deficits. Where stimulants create anxiety, CoQ10 delivers sustainable energy by enhancing metabolic pathways.
- Skin health and photoprotection: Dermatological applications target fibroblast mitochondria, protecting against UV-induced oxidative damage and collagen degradation. Beauty-from-within formulations pair CoQ10 with collagen peptides and hyaluronic acid.
- Deep cream penetration: Liposomal encapsulation enables CoQ10 to cross the stratum corneum barrier, reaching viable epidermal and dermal layers where standard molecules cannot penetrate.
- Cellular energy restoration: CoQ10 delivered to dermal fibroblasts restores mitochondrial function, directly supporting collagen and elastin synthesis at the biochemical level.
- Antioxidant protection: Liposomal ubiquinol neutralises UV-induced free radicals within dermal tissue, protecting against photoageing and collagen degradation in cream applications.
- Formulation stability: Liposomal encapsulation maintains the reduced ubiquinol form throughout cream shelf life, preventing oxidative degradation that compromises standard CoQ10 topical formulations.
01
Why does absorption matter more than dosage with CoQ10?
CoQ10 weighs 863 daltons and dissolves only in fat, making intestinal uptake difficult. Standard supplements deliver only 3-5% to the bloodstream, regardless of the number of capsules taken.
03
Can liposomal CoQ10 replace intravenous administration in hospitals?
IV remains the gold standard for acute heart failure, but it isn’t practical long-term. Liposomal oral delivery achieves 60-70% of IV bioavailability, transforming CoQ10 into a viable outpatient therapy.
05
What differentiates Lipoedge from other liposomal CoQ10 suppliers?
Many brands claim “liposomal” status by simply mixing lecithin, without actually forming vesicles. Lipoedge verifies each batch by electron microscopy, confirming that it contains real liposomes that meet published specifications.
02
How do cardiologists verify adequate CoQ10 tissue levels?
Plasma testing targets >2.5 μg/mL for cardiovascular benefit, a level that standard supplements rarely achieve. Lipoedge reaches therapeutic range at 100-150mg, whereas crystalline requires 300-600mg inconsistently.
04
Why don't statin manufacturers include CoQ10 in medications?
Pharmaceutical companies explored combination pills but faced formulation instability and absorption problems. Liposomal technology now enables reliable co-administration, restoring depleted CoQ10 while maintaining cholesterol reduction.
